<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02509377</url>
  </required_header>
  <id_info>
    <org_study_id>24890</org_study_id>
    <nct_id>NCT02509377</nct_id>
  </id_info>
  <brief_title>Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0</brief_title>
  <acronym>MOMSto40BMI</acronym>
  <official_title>Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Louis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Louis University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of&#xD;
      Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout&#xD;
      the United States. These criteria state exclusion for hypertension and diabetes which are&#xD;
      known co-morbidities for obesity. Investigators plan to expand one exclusion criteria for&#xD;
      open fetal repair surgery. Currently, an exclusion factor is a maternal BMI of 35.0 and&#xD;
      greater.Investigators will maintain all other inclusion and exclusion criteria (including&#xD;
      excluding for hypertension and diabetes) with the exception of expanding the BMI to include&#xD;
      mothers with a BMI of 35.0 to 40.0. Co-morbidities of the research group will be compared to&#xD;
      the comorbidities of the mothers published in the MOMS trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MOMS trial proved prenatal repair of myelomeningocele was an advantage over postnatal&#xD;
      repair for the fetus/neonate/child and is the standard of care for maternal/fetal dyads who&#xD;
      meet the inclusion exclusion criteria. Investigators plan to maintain all inclusion exclusion&#xD;
      criteria for open fetal repair surgery of myelomeningocele with one exception, the expansion&#xD;
      of the maternal BMI to 40.0. This population of mothers with a BMI of 35.0 to 40.0 have not&#xD;
      been studied. The morbidities of these mothers will be compared to morbidities of mothers&#xD;
      with a BMI less than or equal to 34.9 currently in the scientific literature.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Co-morbidities in mothers having fetal MMC repair</measure>
    <time_frame>up to 40 weeks</time_frame>
    <description>Measure the co-morbidity of mothers with a BMI of 35.0 to 40.0. Compare to published data in the MOMS trial.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Myelomeningocele</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>BMI 35.0 to 40.0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mothers who meet all inclusion exclusion criteria for open fetal repair of myelomeningocele except BMI.&#xD;
These mothers have a BMI between 35.0 and 40.0</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Fetal Repair of Myelomeningocele</intervention_name>
    <description>Open Fetal Repair of Myelomeningocele when mothers BMI is elevated</description>
    <arm_group_label>BMI 35.0 to 40.0</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Maternal BMI 35.0 to 40.0&#xD;
&#xD;
          -  No maternal documented co-morbidities&#xD;
&#xD;
          -  Fetal MMC begins between thoracic 1 and sacral 1, on the spinal column.&#xD;
&#xD;
          -  Evidence of fetal hindbrain herniation (hindbrain is being pulled down the spinal&#xD;
             column).&#xD;
&#xD;
          -  A gestational age is between 19 weeks 0 days and 26 weeks with evidence of placental&#xD;
             membrane fusion.&#xD;
&#xD;
          -  Documented normal fetal karyotype.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of maternal alloimmunization problem&#xD;
&#xD;
          -  Kell sensitization&#xD;
&#xD;
          -  Risk of preterm birth&#xD;
&#xD;
          -  History of spontaneous preterm birth&#xD;
&#xD;
          -  Cervix &lt;20mm in length&#xD;
&#xD;
          -  Presence of cerclage&#xD;
&#xD;
          -  Placental problem&#xD;
&#xD;
          -  History of placental abruption&#xD;
&#xD;
          -  Placental Previa&#xD;
&#xD;
          -  Body-mass index of 40.1 or more&#xD;
&#xD;
          -  Maternal contraindication to surgery&#xD;
&#xD;
          -  Insulin-dependent pregestational diabetes&#xD;
&#xD;
          -  Hypertension or preeclampsia&#xD;
&#xD;
          -  HIV, hepatitis-B, or hepatitis-C positive&#xD;
&#xD;
          -  Other medical condition of risk to mother&#xD;
&#xD;
          -  Uterine problem&#xD;
&#xD;
          -  Previous hysterotomy in the active uterine segment&#xD;
&#xD;
          -  Severe fibroids&#xD;
&#xD;
          -  Uterine malformation (bicornuate, arcuate, unicornuate, didelphys)&#xD;
&#xD;
          -  No support person for periprocedural period&#xD;
&#xD;
          -  Inadequate support at home for pregnancy&#xD;
&#xD;
          -  Inadequate understanding of risks and benefits of fetal surgery&#xD;
&#xD;
          -  Inability to comply with medical restrictions, follow up after fetal surgery&#xD;
&#xD;
          -  Multiple gestation pregnancy (twins, triplets, etc.)&#xD;
&#xD;
          -  A fetal anomaly unrelated to myelomeningocele (heart defect, lung lesions)&#xD;
&#xD;
          -  Severe fetal kyphosis &gt;30 degrees (curvature of the back)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emanuel Vlastos, Associate Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Louis University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SSM Cardinal Glennon Fetal Care Institute</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17;364(11):993-1004. doi: 10.1056/NEJMoa1014379. Epub 2011 Feb 9.</citation>
    <PMID>21306277</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>July 23, 2015</study_first_submitted>
  <study_first_submitted_qc>July 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>June 26, 2018</last_update_submitted>
  <last_update_submitted_qc>June 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fetal Surgery</keyword>
  <keyword>Open Fetal Surgery</keyword>
  <keyword>Elevated BMI</keyword>
  <keyword>Body Mass Index</keyword>
  <keyword>Spina Bifida</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningomyelocele</mesh_term>
    <mesh_term>Spina Bifida Cystica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

